Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000570148

Apexbio Technology LLC DANTROLENE-100MG
SDP

Catalog No. 5000570148
Encompass_Preferred

Dantrolene (CAS No 7261-97-4) is a hydantoin derivative primarily used in the research category of muscle relaxants originating from its unique ability to interfere with excitation-contraction coupling in skeletal muscle Its mechanism of action involves blocking the ryanodine receptor (RyR1) calcium channels in the sarcoplasmic reticulum reducing calcium release and subsequent muscle contraction In vitro it exhibits activity in the nanomolar to low micromolar range Dantrolene is frequently applied in studies utilizing cell models to investigate calcium dynamics and neuroprotection as well as in animal studies exploring its potential in treating conditions such as malignant hyperthermia and muscular dystrophies It is also used in drug screening for therapeutic agents targeting calcium-related disorders Experimental concentrations typically depend on the specific research design

Catalog No. 50-005-70148 Supplier Apexbio Technology LLC Supplier No. BA3594100
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Dantrolene (CAS No 7261-97-4) is a hydantoin derivative primarily used in the research category of muscle relaxants originating from its unique ability to interfere with excitation-contraction coupling in skeletal muscle Its mechanism of action involves blocking the ryanodine receptor (RyR1) calcium channels in the sarcoplasmic reticulum reducing calcium release and subsequent muscle contraction In vitro it exhibits activity in the nanomolar to low micromolar range Dantrolene is frequently applied in studies utilizing cell models to investigate calcium dynamics and neuroprotection as well as in animal studies exploring its potential in treating conditions such as malignant hyperthermia and muscular dystrophies It is also used in drug screening for therapeutic agents targeting calcium-related disorders Experimental concentrations typically depend on the specific research design

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.